12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Omeros completes follow-on

Omeros Corp. (NASDAQ: OMER), Seattle, Wash.
Business: Inflammation, Neurology, Ophthalmic
Date completed:...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >